Sporogenics

Sporogenics is a Singapore-based biomedical company specializing in the development of advanced biodegradable implants and drug-eluting biomaterials designed to prevent post-surgical complications. The company's core technology, the S-GEL platform, is a bio-resorbable hydrogel that acts as a physical barrier to prevent tissue adhesions while simultaneously delivering therapeutic agents to promote healing. Their lead programs focus on preventing abdominal and pelvic adhesions, which are common and costly complications following surgery. By combining material science with localized drug delivery, Sporogenics aims to improve surgical outcomes and reduce the need for follow-up procedures.